The White House is boosting efforts to get a bill through the US Congress that curbs prescription drug costs, as President Donald Trump faces impeachment hearings amid the 2020 election campaign, as reported by CTV News.
"This is a once-in-a-generation opportunity to confront these issues in a nonideological fashion," said Joe Grogan, a domestic policy adviser to the president, but "unfortunately, there are some current complications."
Trump is backing a compromise bipartisan bill in the Senate, which does not give Medicare bargaining authority, but forces drugmakers to pay rebates if they raise prices too high.
However, Senate Majority Leader Mitch McConnell has made no public commitment to bring it to the floor.
Grogan said the administration is working to line up Republican support for the Senate bill while trying to sweeten its impact by plowing more of the government's savings from reduced drug prices into benefits for seniors.
Meanwhile, the more ambitious House Democratic bill would build on the Senate's foundation, but also authorize Medicare to negotiate prices for the most expensive drugs.